| Proteomics and machine learning approaches reveal a set of prognostic markers for COVID-19 severity with drug repurposing potential K Suvarna, D Biswas, MGJ Pai, A Acharjee, R Bankar, V Palanivel, ... Frontiers in physiology 12, 652799, 2021 | 67 | 2021 |
| Role of multiomics data to understand host–pathogen interactions in COVID-19 pathogenesis S Aggarwal, A Acharjee, A Mukherjee, MS Baker, S Srivastava Journal of Proteome Research 20 (2), 1107-1132, 2021 | 39 | 2021 |
| Proteomic investigation reveals dominant alterations of neutrophil degranulation and mRNA translation pathways in patients with COVID-19 R Bankar, K Suvarna, S Ghantasala, A Banerjee, D Biswas, M Choudhury, ... Iscience 24 (3), 2021 | 34 | 2021 |
| Immunoinformatics approach for a novel multi-epitope subunit vaccine design against various subtypes of Influenza A virus S Sharma, V Kumari, BV Kumbhar, A Mukherjee, R Pandey, K Kondabagil Immunobiology 226 (2), 152053, 2021 | 26 | 2021 |
| Proteomics advances towards developing SARS-CoV-2 therapeutics using in silico drug repurposing approaches A Mukherjee, A Verma, S Bihani, A Burli, K Mantri, S Srivastava Drug Discovery Today: Technologies 39, 1-12, 2021 | 7 | 2021 |
| Insights on proteomics-driven body fluid-based biomarkers of cervical cancer A Mukherjee, CB Pednekar, SS Kolke, M Kattimani, S Duraisamy, ... Proteomes 10 (2), 13, 2022 | 5 | 2022 |
| Insights on Proteomics-Driven Body Fluid-Based Biomarkers of Cervical Cancer. Proteomes 2022, 10, 13 A Mukherjee, CB Pednekar, SS Kolke, M Kattimani, S Duraisamy, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | | 2022 |
